COVID-19
Long COVID: Chronic Inflammation and T Cell Dysfunction
JAK–STAT, IL-6, and Interferon Signaling Pathways as Potential Therapeutic Targets
Nasal Interferon Reduces the Period of Infectiousness in Children Infected With Coronavirus
Shortening the Period – Containing the Pandemic
Autoantibodies to Interferon Alpha in Patients With Antibody Deficiency
Autoantibodies Are Rare and Do Not Affect Coronavirus Vaccination
Seven Puzzles of Coronavirus
Pneumonia, MIS-C, Neuro-COVID, COVID Toes, Post-COVID Syndrome, Resistance to Infection, and Adverse Reactions to mRNA Vaccines
How Aging Alters the Response to Coronavirus
STAT3-Dependent Processes – The Basis of Severe COVID-19 in the Elderly
Influenza and COVID-19 – Potential Triggers of Cancer Progression
Respiratory Viruses Elevate IL-6 Levels, Activating Dormant Breast Cancer Cells
Next-Generation Cancer and Virus Vaccines: The SABER Platform
SABER molecules enhance cross-presentation by improving antigen delivery to the endoplasmic reticulum
Tonsils as a Potential Reservoir for Coronavirus
SARS-CoV-2 Penetrates Tonsils and Suppresses Immune Response
Tonsil Removal Reduces the Risk of COVID-19
Study on Over 500,000 Individuals
How Nasopharyngeal Lymphoid Tissue Responds to SARS-CoV-2 in Adults
Lymphoid Tissue Provides Coordinated Defense Against Viruses
Rapid Decline of Interferon-α2 is Associated with the Risk of Death from COVID-19
Type I Interferon Treatment May Help Severe Patients
Early Interferon Response Protects Against Coronavirus Infection Despite Exposure
Increased IFN-Related Gene Activity Within 6 Hours After Exposure Prevents Infection
Diagnosing ARVI via Interferon Levels
Nasal Interferon Levels Combined with PCR Testing Improve Diagnostic Accuracy to 94%
Persistence of SARS-CoV-2 in Alveolar Macrophages is Regulated by IFN-γ and NK Cells
SARS-CoV-2 Exploits MHC-E to Evade the Immune Response
Interstitial Macrophages: Key Culprits in Severe COVID-19
The Coronavirus Exploits Interstitial Macrophages for Replication
COVID-19 Enhances Flu Response by Creating Innate Immune Memory
Coronavirus alters the genetic activity of alveolar macrophages
Impaired Tolerance of Self-Tissues Leads to Autoantibodies Against IFN-I
Autoantibodies against type I interferons (IFN-I) increase susceptibility to severe infections
The Cause of Fatigue in Post-COVID Syndrome: Tryptophan Catabolites, Inflammation, and Insulin Resistance
Early Control of Inflammation Can Reduce the Risk of Severe Post-COVID Syndrome
Predicting the Success of COVID-19 Treatment with Dexamethasone Based on Monocyte Gene Activity
Dexamethasone: Not Just an Immunosuppressant but Also an Immunomodulator
Interferon-γ Contributes to Respiratory Complications After COVID-19
Blocking IFN-γ: A New Approach to Treating Post-COVID Syndrome
How the Body Responds to Coronavirus at Different Stages of Infection
Scientists Infect Volunteers with SARS-CoV-2 to Understand the Immune System's Battle Against the Virus
Pharmacodynamics of Nasal Interferon Alpha-2b and Effective Prevention of Coronavirus Infection
Research on high-risk groups
WHO Recommendations for Staying Safe as COVID-19 Re-Emerges
The World Health Organization (WHO) has issued new recommendations in response to the rising incidence of FLiRT, a new strain of COVID-19, in the UK and other European countries
Genetic Roots of Severe Infections: From Coronavirus to EBV
Why Some Children Suffer More Severely
Artificial Intelligence Predicts Post-COVID Syndrome by Gut Microbiome
Symptoms of Long COVID Depend on Gut Bacteria
Blood Markers Associated with Post-COVID Syndrome
Symptoms of post-COVID syndrome can be predicted based on elevated plasma proteins
From Cold to Pneumonia: The Role of Macrophages in Coronavirus
Activated Interstitial Macrophages as a Target for COVID-19 Treatment
Autoantibodies to Interferons Are Not Associated with Chronic Fatigue after COVID-19
Only 1.6% of patients with post-COVID syndrome had autoantibodies to IFN-β
Autoantibodies to Type I Interferons in COVID-19 Patients
Autoantibodies to tissues, immune cells and interferons complicate the course of COVID-19
Genetic Trick of Omicron: Evasion of the Innate Immune System
Coronavirus gene Orf6 suppresses immune responses
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Why Does Coronavirus Make You Sneeze
The coronavirus protein enhances pain sensitivity
How the Complement System Contributes to Post-COVID Syndrome
Tissue Damage and Herpes Virus Reactivation Increase Complement Activity
COVID-19 and Autoimmune Neurological Disorders: Vaccination Safety
How coronavirus vaccination affects patients with multiple sclerosis, myasthenia gravis and neuromyelitis optica
Quercetin – an Antioxidant with Neuroprotective and Antiviral Properties
Overview of the Therapeutic Effects of Quercetin
Cardiovascular Risks in COVID-19 vs. Other Pulmonary Infections: A Comparative Analysis
Patients with COVID-19 often exhibit myocardial damage, associated with adverse outcomes and high mortality rates
Antibody-Free Protection: The Effectiveness of COVID-19 Vaccination in Patients with B-Cell Deficiency
Enhanced T-cell responses with B-cell deficiency reduce the risk of severe COVID-19 by 5-fold
Confronting the Invisible Enemy: How Viral Reservoirs Impact Health Post COVID-19
Mechanisms through which coronavirus can remain in the body and their role in post-COVID syndrome
Post-COVID Syndrome Linked to Low Serotonin Levels
Viral inflammation disrupting serotonin synthesis and accumulation
A Pan-Coronavirus Nasal Vaccine Developed in Hong Kong
A nasal vaccine containing interferon protects Omicron and other coronavirus strains
Protection Against Omicron: New Vaccines on the Horizon
The World Health Organization has recommended a monovalent vaccine based on the Kraken strain, a subvariant of Omicron
COVID-19 Increases the Risk of Osteoporosis
Inflammatory Cytokines Trigger Bone Tissue Degradation
Interferon Alpha-2b Enhances Protection Against Omicron in Vaccinated Individuals
A Study on High-Risk Medical Workers
Coronavirus Pyrola: Do Vaccines and Previous Infection Protect Against Other Strains?
Mutations in the Spike Protein Help Pyrola Evade Immune Protection
Post-COVID Syndrome and Multi-Organ Failure
Three Out of Five People with Post-COVID Syndrome Experience Organ Dysfunction
Properties and Antiviral Activity of Interferon Epsilon
IFN-ε may protect against HIV
Modified Interferon α2 Inhibits Coronavirus Replication and Inflammation
IFNmod protects against IFN-I-associated lung injury
Metformin Reduces COVID-19 Severity in Prediabetic Patients
For patients with PCOS, results are similar
Asymptomatic Coronavirus Gene Found
Mutation of the HLA system gene helps trigger antiviral response faster
Indigenous Peoples in Australia More Severely Ill COVID-19
The reason for the weak antibody response is chronic diseases
Efficacy and Safety of Type I and III Interferons in the Treatment of COVID-19
Systematic review and meta-analysis
Prevention of COVID-19 in Pregnant Women
Evaluation of the effectiveness of intranasal and rectal interferon-alpha, vaccination and umifenovir
The Introduction of Intranasal Interferon-Alpha During COVID-19 Vaccination Increases the Effectiveness and Longevity of Vaccines
IFN-alpha forms sterilizing immunity of the mucous membranes of the upper respiratory tract
How Paracetamol Acts in Flu
NSAIDs change neuronal response to influenza, reducing mortality
Type I Interferon Protects against Hyperinflammation and Tissue Damage
Interferon inhibits the production of enzymes by macrophages that destroy tissue structure
Post-Covid-19 Cognitive Impairment Associated with Antiviral Type I Interferon Response in the Choroid Plexus
Restoring systemic immunity and regular IFN-gamma activity may prevent cognitive impairment
Early COVID-19 Treatment with Pegylated Interferon-Lambda
Single subcutaneous injection of IFN-lambda prevents hospitalization and reduces mortality
COVID-19 Complication: Facial Nerve Palsy Associated with Fungal Infection
Immunosuppression in COVID-19 contributes to the development of mucormycosis
Simultaneous COVID-19 and Flu: How Coinfection Affects The Outcome of The Disease
Impact of influenza on coronavirus infection
Influenza Virus Interferes with Coronavirus’ Ability to Infect Lungs and Heart
The role of interferon and nitric oxide in the suppression of coronavirus replication
Fungal Infections with Coronavirus
Candida fungus linked to COVID-19 deaths
Cause of Mental Disorders in COVID-19
Inflammatory proteins disrupt hippocampal neurogenesis
Ways to Overcome Chronic Fatigue after COVID-19
Post-Covid Syndrome Treatment: Vagus Nerve Stimulation
Interferon-α2b Spray Shortens The Infectious Period of Omicron
Only administration up to 3 days from the onset of the disease is effective
How Much Virus Does A Person With COVID-19 Breathe Out
Patients with Omicron can shed 1,000 times more viral RNA than with Alpha and Delta strains
Omicron and Delta are The Most Interferon-Resistant COVID-19 Strains
IFN-alpha8, IFN-beta, and IFN-omega coronavirus are most effectively suppressed
IgM Antibodies Protect Against Delta and Omicron Strains
IgM antibodies derived from memory B cells neutralize a wide range of coronavirus strains
Nasal Interferon is Only Effective if Administered before COVID-19 Symptoms Appear
Interferon-alpha is effective the day before or one day after infection with SARS-CoV-2
Omicron is Resistant to Interferon Response
However, exogenous interferon inhibits Omicron
Nasal Vaccines Against COVID-19
Nasal vaccines, in addition to intramuscular ones, stimulate mucosal immunity
Interferon to Prevent and Treat Respiratory Viral Infections
Review of human studies
COVID-19 and Down Syndrome
Increased activity of the interferon system complicates the course of COVID-19
The Post-COVID Syndrome: Symptoms, Causes, Treatment
Chronic inflammation of the heart and acute kidney injury after COVID-19
Cognitive Impairment After COVID-19: Brain Fog And Memory Problems
Is Cognitive Recovery Possible After COVID-19?
GMOP-IFN-Alpha-2b: Stable De-Immunized Interferon
Non-immunogenic interferon with a long elimination period can help in the treatment of chronic hepatitis and other viral diseases
Pegylated Interferon-Lambda Protects Against Severe COVID-19
A single subcutaneous injection of interferon-lambda twice reduces the risk of hospitalizations with COVID-19
Inflammatory Cytokines Cause Cardiac Arrhythmias in COVID-19
Cytokines IL-6 and IL-10 are risk factors for atrial and ventricular arrhythmias
ACE2 Decoy Prevents Omicron Infection
Engineered ACE2 prevents the coronavirus from binding to the cell
Diet in COVID-19: Five Facts About Antiviral Nutrition
How dietary habits, vitamins, and trace elements affect immunity
Genetic Disorders Cause Smell Loss In COVID-19
COVID-19 impairs sensory neuron function by suppressing olfactory receptor genes
Intranasal Interferon-Λ Protects Against Omicron Strain
Type III interferon suppresses coronavirus infection of the upper and lower respiratory tract
Zinc Deficiency Affects Taste Changing After COVID-19
Prescripted Zinc Supplements Accelerate Taste Recovery After COVID-19
Why Omicron is A Milder But More Contagious Disease
Omicron multiplies rapidly in the bronchi but affects the lungs less
Post-Vaccination and Natural COVID-19 Antibodies: Which Protect Better?
S-protein in a closed state as the basis of future vaccines
Physical Activity after COVID-19 and Flu Vaccination Increases The Level of Antibodies
Physical activity stimulates the production of interferon-alpha and increases the effectiveness of vaccines
Interferon-Alpha-2b Inhalations Improve Clinical Outcome in COVID-19
Early treatment with interferon-alpha-2b reduces the risk of severe COVID-19 outcomes by 64%
Interferon-Alpha in COVID-19: A Systematic Review
Interferon-alpha in combination with antivirals accelerates recovery from COVID-19
Omicron: Disease Duration
Quarantine terms for infection with Omicron
Omicron Triggers Interferon Response Leading to Mild COVID-19
How Omicron mutations affect the treatment and course of the disease
Do Vaccines Protect Against Omicron Strain?
Individuals vaccinated with Sputnik V retain a neutralizing response against the Omicron strain
Interferon, Statins, Janus Kinase Inhibitors and Hydroxyurea to Treat COVID-19
What factors influence severe COVID-19?
Combined Interferon And Janus Kinase 1/2 Inhibitor In Treating COVID-19
Ruxolitinib and interferon resist cytokine storm and thrombosis; interferon inhibits viral replication
Vaccination Against COVID-19: Heart Complications Risks
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination and SARS-CoV-2 infection
Common Cold Immunity Protects Children From COVID-19
Protein S2 – a promising basis for future coronavirus vaccines
Severe COVID-19 causes chronic kidney failure
SARS-CoV-2 infects the kidneys and is associated with subsequent fibrosis